These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10220594)

  • 21. Post-Acute Care Takes Center Stage in CMS (Centers for Medicare and Medicaid Services) Plan to Expand Use of Bundled Payments for Heart Attack.
    Kuehn BM
    Circulation; 2016 Nov; 134(19):1503-1504. PubMed ID: 27821421
    [No Abstract]   [Full Text] [Related]  

  • 22. Getting the price right: Medicare payment rates for cardiovascular services.
    Hayes KJ; Pettengill J; Stensland J
    Health Aff (Millwood); 2007; 26(1):124-36. PubMed ID: 17211021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The economic burden of chronic cardiovascular disease for major insurers.
    Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
    Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economics of psychosocial factors in patients with cardiovascular disease.
    Rodwin BA; Spruill TM; Ladapo JA
    Prog Cardiovasc Dis; 2013; 55(6):563-73. PubMed ID: 23621966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncology Care Model: Short- and Long-Term Considerations in the Context of Broader Payment Reform.
    Clough JD; Kamal AH
    J Oncol Pract; 2015 Jul; 11(4):319-21. PubMed ID: 26060221
    [No Abstract]   [Full Text] [Related]  

  • 26. Advocacy for Cardiac CT: The time is now!
    Blankstein R; Thomas D
    J Cardiovasc Comput Tomogr; 2019; 13(5):A3-A4. PubMed ID: 31858975
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcome Measurement in Value-Based Payments.
    Mullangi S; Schleicher S; Feeley TW
    JAMA Oncol; 2017 Aug; 3(8):1019-1020. PubMed ID: 27918757
    [No Abstract]   [Full Text] [Related]  

  • 28. "Come Home": A Medicare Innovation Center project.
    McAneny BL
    Oncology (Williston Park); 2012 Dec; 26(12):1145, 1156. PubMed ID: 23413590
    [No Abstract]   [Full Text] [Related]  

  • 29. The consequences of paying Medicare managed care plans their costs.
    Sing M; Brown R; Hill SC
    Inquiry; 1998; 35(2):210-22. PubMed ID: 9719788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?
    Califf RM
    Stat Med; 2002 Oct; 21(19):2889-97. PubMed ID: 12325105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic and quality of life outcomes in oncology: the regulatory perspective.
    Turner S
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):121-5. PubMed ID: 8608041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review.
    Muszbek N; Brixner D; Benedict A; Keskinaslan A; Khan ZM
    Int J Clin Pract; 2008 Feb; 62(2):338-51. PubMed ID: 18199282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status of the Medicaid competition demonstrations.
    Hurley RE
    Health Care Financ Rev; 1986; 8(2):65-75. PubMed ID: 10312013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Realigning incentives for developing and pricing new anticancer treatments.
    Howard DH
    JAMA; 2011 Jun; 305(22):2347-8. PubMed ID: 21642689
    [No Abstract]   [Full Text] [Related]  

  • 35. Community Guide Cardiovascular Disease Economic Reviews: Tailoring Methods to Ensure Utility of Findings.
    Chattopadhyay SK; Jacob V; Mercer SL; Hopkins DP; Elder RW; Jones CD;
    Am J Prev Med; 2017 Dec; 53(6S2):S155-S163. PubMed ID: 29153116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings of a symposium: economics and cost-effectiveness in evaluating the value of cardiovascular therapies. What constitutes a useful health economic study for the pharmaceutical industry?
    Gagnon JP
    Am Heart J; 1999 May; 137(5):S62-6. PubMed ID: 10220599
    [No Abstract]   [Full Text] [Related]  

  • 37. Decision Aids and Elective Joint Replacement - How Knowledge Affects Utilization.
    Ibrahim SA
    N Engl J Med; 2017 Jun; 376(26):2509-2511. PubMed ID: 28657869
    [No Abstract]   [Full Text] [Related]  

  • 38. Use and impact of patient relationship modifiers on cost measurement.
    Larson RA; Johnson B; Woo K; Rathbun JA; Copeland TP
    J Vasc Surg; 2018 Jul; 68(1):307. PubMed ID: 29937035
    [No Abstract]   [Full Text] [Related]  

  • 39. Costs of occupational circulatory disease.
    Leigh JP; Schnall P
    Occup Med; 2000; 15(1):257-67, v. PubMed ID: 10702089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of medical nutrition therapy and therapeutically designed meals for older adults with cardiovascular disease.
    Troyer JL; McAuley WJ; McCutcheon ME
    J Am Diet Assoc; 2010 Dec; 110(12):1840-51. PubMed ID: 21111094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.